NEW YORK – The companies that have developed Coronavirus vaccines stand to make record-breaking sales in the coming months.
Wall Street analysts project Pfizer and Moderna will generate $32 billion in vaccine revenue next year alone.
The companies will also likely profit from a boost in public good-will for helping end the pandemic.
That publicity will be especially valuable for Moderna, a relatively new biotech company a lot of people hadn’t heard of before 2020.
Morgan Stanley Projects Pfizer will make $19 billion in Coronavirus vaccine revenue in 2021.
Pfizer will split that revenue with Biontech, the German company it partnered with to develop the vaccine.
An FDA advisory panel recommended Thursday that the agency grant emergency use authorization to the Pfizer-Biontech vaccine.